VREOF
Vireo Growth Inc.Company Information
- Company Name
- Vireo Growth Inc.
- CIK
- CIK0001771706
- Category
- <br>Emerging growth company
- Ticker: Exchange
- VREOF: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- VREOF
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-06-13
- Last sale
- —
- Shares purchased (TTM)
- 2,004,478
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 10,000
- Shares outstanding
- 1,080,450,771
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 16.20%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Super Voting Shares | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | -0 | ||||||
| Subordinate Voting Shares | -91 | 91 | 1,057 | 893 | -309 | 339 | 338 | 86 | 4 | 111 | 110 | 22 | ||||||
| Multiple Voting Shares | -0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | ||||||
Assets Current | ||||||||||||||||||
| Cash | 103 | 122 | 102 | 97 | 99 | 86 | 92 | 7 | 11 | 13 | 16 | 13 | ||||||
| Accounts Receivable Net Current | - | - | - | - | - | - | - | 3 | 2 | 3 | 3 | 6 | ||||||
| Restricted Cash Current | 20 | 15 | 20 | 20 | 7 | - | - | - | - | - | - | - | ||||||
| Marketable Securities Current | 1 | 1 | 1 | 1 | 1 | - | - | - | - | - | - | - | ||||||
| Income Taxes Receivable | 21 | 18 | 23 | 14 | 25 | 11 | 12 | 12 | 12 | 12 | 12 | - | ||||||
| Inventory Net | 149 | 76 | 60 | 54 | 63 | 23 | 22 | 20 | 20 | 19 | 19 | 19 | ||||||
| Prepaid Expense And Other Assets Current | 14 | 7 | 4 | 5 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | ||||||
| Derivative Assets Current | 1 | 1 | 2 | 1 | 1 | 2 | 2 | - | - | - | 2 | - | ||||||
| Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current | 1 | 1 | 79 | - | - | - | 0 | 0 | 4 | 4 | 4 | 4 | ||||||
| Nontrade Receivables Current | - | - | - | - | - | - | - | 5 | 5 | 3 | 2 | 2 | ||||||
| Assets Held For Sale Not Part Of Disposal Group Current | - | 0 | 0 | 102 | 102 | 100 | 97 | 95 | 93 | 92 | 91 | 90 | ||||||
| Other Assets Miscellaneous Current | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Assets Current | 395 | 258 | 305 | 308 | 313 | 228 | 230 | 144 | 149 | 147 | 149 | 135 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 281 | 232 | 218 | 121 | 111 | 33 | 32 | 31 | 26 | 24 | 23 | 24 | ||||||
| Operating Lease Right Of Use Asset | 154 | 84 | 53 | 37 | 37 | 8 | 8 | 11 | 11 | 11 | 2 | 2 | ||||||
| Intangible Assets Net Excluding Goodwill | 219 | 194 | 117 | 90 | 86 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | ||||||
| Goodwill | 161 | 124 | 88 | 97 | 73 | - | 0 | - | - | - | 0 | 0 | ||||||
| Long Term Investments | 12 | 6 | 6 | 6 | 13 | - | - | - | - | - | - | - | ||||||
| Deposits Assets Noncurrent | 4 | 4 | 4 | 2 | 9 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | ||||||
| Deferred Income Tax Assets Net | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Other Assets Noncurrent | - | - | - | - | 0 | - | - | - | - | - | - | - | ||||||
| Assets | 1,274 | 929 | 817 | 679 | 659 | 277 | 279 | 194 | 195 | 191 | 183 | 172 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 125 | 58 | 50 | 39 | 47 | 12 | 10 | 9 | 9 | 8 | 8 | 34 | ||||||
| Convertible Debt Current | 1 | 1 | 1 | 2 | - | - | - | - | - | - | - | - | ||||||
| Secured Debt Current | 42 | 16 | 16 | 16 | 26 | - | 1 | 1 | 62 | 61 | 60 | 55 | ||||||
| Derivative Liabilities Current | - | - | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation | - | - | - | 89 | 89 | 89 | 89 | 88 | 88 | 88 | 88 | 75 | ||||||
| Operating Lease Liability Current | 13 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Business Combination Contingent Consideration Liability Current | 37 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Current | 391 | 216 | 192 | 235 | 244 | 138 | 135 | 129 | 187 | 184 | 179 | 165 | ||||||
| Finance Lease Liability Noncurrent | 9 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 141 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Secured Long Term Debt | 257 | 197 | 128 | 132 | 82 | 63 | 61 | 57 | 1 | - | - | 4 | ||||||
| Convertible Debt Noncurrent | 22 | 8 | 9 | 8 | 10 | 10 | 10 | - | 10 | 9 | 9 | 5 | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | - | 30 | 24 | 15 | 11 | - | - | - | - | - | - | - | ||||||
| Deferred Income Tax Liabilities Net | 10 | 8 | 10 | - | - | - | - | - | - | - | - | - | ||||||
| Other Liabilities Noncurrent | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 831 | 635 | 510 | 433 | 391 | 227 | 223 | 205 | 217 | 213 | 199 | 185 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital Common Stock | 763 | 614 | 607 | 525 | 521 | 288 | 287 | 205 | 188 | 188 | 187 | 186 | ||||||
| Retained Earnings Accumulated Deficit | -320 | -320 | -300 | -279 | -253 | -238 | -231 | -216 | -211 | -210 | -203 | -199 | ||||||
| Stockholders Equity | 443 | 294 | 307 | 246 | 269 | 51 | 56 | -11 | -23 | -23 | -16 | -13 | ||||||
| Liabilities And Stockholders Equity | 1,274 | 929 | 817 | 679 | 659 | 277 | 279 | 194 | 195 | 191 | 183 | 172 | ||||||
Common Stock Number Of Shares Par Value And Other Disclosures | ||||||||||||||||||
| Allowance For Doubtful Accounts Receivable Current | - | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock No Par Value | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialVireo Growth Inc. (VREOF) — SEC Financial Statements & Analysis
Vireo Growth Inc. (VREOF) is a pharmaceutical preparations company, incorporated in A1. Vireo Growth Inc. trades on OTC as: VREOF. Vireo Growth Inc. (VREOF)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Vireo Growth Inc. carries a market cap of $452.67M, a P/E ratio of -6.74x, a P/B ratio of 1.02x, a P/S ratio of 0.88x, an enterprise value of $661.17M, and an EV/EBITDA multiple of 43.24x. On profitability, it posts a gross margin of 48.64%, an operating margin of 0.32%, a net margin of -13.12%, a Return on Equity (ROE) of -18.88%, a Return on Assets (ROA) of -6.94%, and a Return on Invested Capital (ROIC) of 0.00%. Per share, it reports EPS of $-1.49, diluted EPS of $-1.49, free cash flow per share of $-2.58, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 316.71% year-over-year, net income growth of 59.69% year-over-year, and EPS growth of -33.99% year-over-year. On the balance sheet, it maintains a current ratio of 1.01x, a quick ratio of 0.59x, working capital of $3.80M, a debt-to-equity ratio of 1.88x, a debt ratio of 0.65, an interest coverage ratio of 0.09x, free cash flow of $-116.31M (TTM), and net debt of $208.50M. Figures sourced from SEC EDGAR.
- Market Cap
- $452.67M
- P/E TTM
- -6.74x
- EPS TTM
- $-1.49
- P/B TTM
- 1.02x
- ROE TTM
- -18.88%
- ROA TTM
- -6.94%
- Debt To Equity
- 1.88x
- Free Cash Flow TTM
- $-116.31M
- Net Revenue TTM Growth 1Y
- 316.71%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Vireo Growth Inc. in?
Vireo Growth Inc. (VREOF) operates in the Pharmaceutical Preparations industry.
What exchange does VREOF trade on?
Vireo Growth Inc. (VREOF) trades on the OTC.
Where is Vireo Growth Inc. incorporated?
Vireo Growth Inc. is incorporated in British Columbia, Canada.
When was Vireo Growth Inc. (VREOF)'s most recent SEC filing?
Vireo Growth Inc. (VREOF)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is VREOF's market cap?
Vireo Growth Inc. (VREOF) has a market capitalization of $452.67M as of 2026-06-30.
What is VREOF's EPS (earnings per share)?
Vireo Growth Inc. (VREOF)'s trailing twelve month EPS is $-1.49 as of 2026-06-30.
What is VREOF's ROE (return on equity)?
Vireo Growth Inc. (VREOF)'s trailing twelve month Return on Equity (ROE) is -18.88% as of 2026-06-30.
What is VREOF's ROA (return on assets)?
Vireo Growth Inc. (VREOF)'s trailing twelve month Return on Assets (ROA) is -6.94% as of 2026-06-30.
What is VREOF's ROIC (return on invested capital)?
Vireo Growth Inc. (VREOF)'s trailing twelve month Return on Invested Capital (ROIC) is 0.00% as of 2026-06-30.
What is VREOF's EV/EBITDA?
Vireo Growth Inc. (VREOF)'s trailing twelve month EV/EBITDA is 43.24x as of 2026-06-30.